Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson’s disease
Darian Williams(National Institutes of Health), Yu Chen(National Human Genome Research Institute)
Cited by 3
Related Papers
Bidirectional regulation of glycoprotein nonmetastatic melanoma protein B by β-glucocerebrosidase deficiency in <i>GBA1</i> isogenic dopaminergic neurons from a patient with Gaucher disease and parkinsonism
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0
GBA1 HDR Donor Vector Assembly v1
|Unknown|2025|0